Market Research Logo

Europe Pharmaceuticals & Healthcare Report Q4 2017

Europe Pharmaceuticals & Healthcare Report Q4 2017

BMI View: Opportunities for multinational pharmaceutical firms differ between the developed Western and the emerging European markets. While innovative drugmakers will continue to favour the developed markets, they will face headwinds in the form of increasing cost-containment in the face of rising demand for chronic disease treatments. Emerging European markets will continue to represent high-growth opportunities due to expansion of healthcare access, although these markets will be favoured primarily by generic drug manufacturers.


BMI Industry View
Table: Headline Regional Pharmaceuticals & Healthcare Forecasts (2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Regional Pharmaceutical Sales, Historical Data And Forecasts, Europe (2013-2021)
Healthcare Market Forecast
Table: Regional Healthcare Expenditure Trends, Historical Data And Forecasts, Europe (2013-2021)
Industry Risk Reward Index
Western Europe Pharmaceuticals: Large Market Sizes Boost Attractiveness
Central And Eastern Europe Pharmaceuticals: A Mixture Of Opportunities
Market Overview
Industry Trend Analysis
Regional Themes - Europe
Industry Trends & Developments
Industry Trends And Developments
Table: Europe Pharmaceutical Market (USDbn)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report